Ashwagandha and Panic Attacks

Ashwagandha and Panic Attacks is a topic that deserves a careful answer: panic attacks are acute episodes of intense fear and physical symptoms, while most ashwagandha research examines broader stress, anxiety, or sleep outcomes. Ashwagandha may be relevant for some people whose panic symptoms occur alongside persistent stress or poor sleep, but it has not been established as a treatment for panic disorder or as a way to stop an attack in progress.

The Evidence Base

The most important distinction is between anxiety symptoms and panic attacks. Anxiety can be persistent and diffuse, involving worry, tension, irritability, sleep disruption, and difficulty concentrating. Panic attacks are more abrupt, often peaking within minutes, and can include palpitations, chest discomfort, trembling, shortness of breath, dizziness, nausea, or fear of losing control.

The provided research does support the possibility that ashwagandha root extract can improve some measures of stress and anxiety in adults. It does not directly demonstrate that ashwagandha prevents panic attacks, reduces their frequency, or treats panic disorder. That gap matters because a supplement that supports long-term stress regulation is not necessarily an acute intervention for a panic episode.

Chandrasekhar et al. (2012) conducted a prospective, randomized, double-blind, placebo-controlled trial in adults with chronic stress. Participants receiving a high-concentration full-spectrum ashwagandha root extract had larger reductions in perceived stress and anxiety-related measures than the placebo group over the study period. The study also reported reductions in serum cortisol, a hormone involved in the body’s stress-response system.

Langade et al. (2019) studied ashwagandha root extract in adults with insomnia and anxiety. Their randomized, double-blind, placebo-controlled design found improvements in sleep-related outcomes and anxiety measures in the ashwagandha group. This is relevant because disrupted sleep can increase physiological arousal and make anxious symptoms harder to manage, although the study did not focus specifically on panic attacks.

Pratte et al. (2014) reviewed human trials of ashwagandha for anxiety. Their review concluded that the available studies suggested potential benefit, while also emphasizing limitations in the evidence base. Those limitations included variation in study methods, preparations, and outcome measures—important reasons not to treat the findings as proof that every ashwagandha product will produce the same result.

Study	Design and population	Intervention reported	Most relevant outcome	What it does not establish
Chandrasekhar et al. (2012)	Randomized, double-blind, placebo-controlled trial in adults with chronic stress	High-concentration full-spectrum ashwagandha root extract, 300 mg twice daily	Improved stress and anxiety-related measures; lower cortisol versus placebo	Treatment or prevention of panic attacks
Langade et al. (2019)	Randomized, double-blind, placebo-controlled trial in adults with insomnia and anxiety	Ashwagandha root extract, 300 mg twice daily	Improved sleep-related and anxiety outcomes	Rapid relief during an active panic episode
Pratte et al. (2014)	Systematic review of human anxiety trials	Multiple ashwagandha preparations and trial designs	Potential anxiolytic benefit, with evidence limitations	A single standardized clinical recommendation for panic disorder
Wankhede et al. (2015)	Human supplementation study in resistance-trained men	Ashwagandha root extract, 300 mg twice daily	Muscle strength and recovery outcomes	Evidence for panic symptoms or anxiety treatment
Choudhary et al. (2017)	Human trial examining memory and cognitive function	Ashwagandha root extract, 300 mg twice daily	Memory and cognitive-function outcomes	Evidence for panic attacks

Two of the provided studies—Wankhede et al. (2015) and Choudhary et al. (2017)—used ashwagandha root extract but investigated strength/recovery and cognitive outcomes, respectively. They help show that standardized root extracts have been studied in humans across several contexts. They should not be used as evidence that ashwagandha treats anxiety or panic symptoms.

For a broader discussion of the anxiety-specific evidence and its limits, see the Ashwagandha Anxiety Full Review. The practical conclusion is modest: human randomized trials support possible benefits for chronic stress, anxiety measures, and sleep in selected adult populations. The evidence for panic attacks themselves remains limited.

The Mechanism: Why Stress Biology May Matter

Ashwagandha is commonly described as an adaptogen, a term generally used for compounds proposed to influence how the body responds to stress. That label is not a diagnosis or a guarantee of clinical benefit. Its practical relevance depends on whether changes in stress physiology translate into meaningful improvements in symptoms for a specific person.

The central biological system here is the hypothalamic-pituitary-adrenal (HPA) axis. In simplified terms, the brain detects a threat or stressor, signaling pathways activate hormone release, and the adrenal glands produce cortisol. Cortisol is necessary for normal physiology, but repeated or poorly regulated activation can accompany chronic stress, sleep disruption, and heightened vigilance.

Chandrasekhar et al. (2012) reported lower serum cortisol in the ashwagandha group compared with placebo. This finding provides a plausible biological link between ashwagandha supplementation and changes in perceived stress. It does not mean that cortisol is “bad,” that everyone with anxiety has high cortisol, or that lowering cortisol is automatically the right goal.

Panic attacks involve more than the HPA axis. They can include rapid activation of the autonomic nervous system, particularly the sympathetic “fight-or-flight” response. Bodily sensations such as a racing heart, breathlessness, or dizziness may then be interpreted as dangerous, escalating fear and physical arousal in a self-reinforcing loop.

A supplement that modestly improves chronic stress or sleep may help lower the background conditions that make this loop easier to trigger in some people. But that is an inference, not a finding directly tested in the provided trials. None of the cited studies measured panic-attack onset, duration, symptom severity during attacks, emergency-care use, or panic-disorder remission.

Sleep is another plausible pathway. Langade et al. (2019) found improvements in insomnia-related and anxiety outcomes with ashwagandha root extract. Poor sleep can reduce emotional resilience, worsen fatigue, and make normal bodily sensations feel more alarming; however, improving sleep does not substitute for evaluating persistent or severe panic symptoms.

For more detail on this stress-signaling system, read HPA Axis Explained. The useful framing is not that ashwagandha “switches off” stress, but that it may influence stress-related pathways over time in some adults.

What Ashwagandha Does Not Show for Panic Attacks

The current evidence does not support using ashwagandha as a rescue treatment during a panic attack. The trials cited here evaluated outcomes over weeks, not minutes. If someone is already experiencing intense chest pain, fainting, severe breathing difficulty, new neurological symptoms, or feels at risk of harming themselves, they should seek urgent medical help rather than relying on a supplement.

It is also important not to self-diagnose a panic attack when symptoms are new or unexplained. Palpitations, chest discomfort, tremor, shortness of breath, and dizziness can have multiple causes. A clinician can help determine whether anxiety is the likely explanation and whether another condition needs evaluation.

Even when panic disorder is present, the research supplied here does not compare ashwagandha with established clinical care. It does not show whether ashwagandha works alongside psychotherapy, prescription medication, or other treatments. It also does not establish whether it is appropriate for people with recurrent, disabling attacks.

This does not make ashwagandha irrelevant. It means the claim must match the evidence: ashwagandha root extract may be considered as a supportive option for chronic stress, sleep difficulty, or general anxiety symptoms, with realistic expectations. It should not be presented as a replacement for assessment or treatment of panic disorder.

Practical Application: Product Form, Dose, and Expectations

The best-supported form in the provided studies is a standardized ashwagandha root extract. The trials by Chandrasekhar et al. (2012), Langade et al. (2019), Wankhede et al. (2015), and Choudhary et al. (2017) each reported 300 mg twice daily of root extract. This repeated study dose is useful context, but it is not a universal prescription.

Different products can vary substantially in plant part, extraction method, concentration, and additional ingredients. Results from one studied extract should not automatically be applied to every powder, gummy, blend, or multi-herb formula. When evaluating a product, look for clear labeling of the extract and serving amount rather than assuming that a larger number on the front label means stronger evidence.

Bio:sudo KSM-66 Reishi Restore is most appropriately viewed as a formulation choice, not as evidence of panic-attack treatment. The ashwagandha evidence discussed here relates to standardized root extracts studied over time. Because the provided references do not evaluate the full combined formulation or reishi for panic attacks, those results should not be assumed for the finished product without direct clinical testing.

Expectations should be measured in weeks, not hours. The cited trials assessed changes over sustained supplementation periods, and their outcomes were stress, anxiety, sleep, cognition, or exercise-related measures—not immediate calming. A person seeking a fast strategy for an acute panic episode needs a different plan, ideally one developed with a qualified healthcare professional.

It can also help to track one or two specific outcomes rather than relying on a vague sense of whether a supplement “works.” Examples include sleep quality, daytime tension, frequency of anxious rumination, or the number of days when stress interferes with usual activities. For recurrent panic attacks, tracking attack frequency, triggers, and severity can provide useful information for a clinician, but it should not delay care.

Safety, Uncertainty, and When to Speak With a Clinician

The studies cited here reported that ashwagandha was generally well tolerated in their study populations. “Generally well tolerated” is not the same as risk-free, and it does not predict how every individual will respond. Human trials are typically limited in duration, population size, and ability to identify uncommon adverse effects.

If you take prescription medication, have an ongoing medical condition, are pregnant or breastfeeding, or have a history of complex mental-health symptoms, discuss supplement use with a qualified clinician or pharmacist first. This is especially important when symptoms have changed recently, are severe, or affect work, relationships, sleep, or daily functioning. An individualized review is more useful than a generic internet recommendation.

Some people notice that supplements marketed for stress do not agree with them, whether because of gastrointestinal discomfort, altered sleep, unexpected stimulation, or another subjective effect. If symptoms worsen after starting a supplement, stop treating the reaction as a sign that you need a higher dose. Review the timing, product, and symptoms with a clinician when appropriate.

There is also a psychological safety issue: using a supplement can become a form of reassurance-seeking if someone feels unable to leave home or face normal sensations without it. A supportive supplement may fit into a broader plan, but it should not become the only coping tool. Effective care for panic-related symptoms often includes learning how to respond differently to bodily sensations and fear.

Who Benefits Most

Based on the provided evidence, the people most likely to find ashwagandha relevant are adults with ongoing stress, mild anxiety symptoms, or sleep difficulty occurring alongside anxiety. Chandrasekhar et al. (2012) specifically studied adults with chronic stress, while Langade et al. (2019) studied adults with insomnia and anxiety. These are the populations most directly connected to the available randomized trial evidence.

A person whose panic-like symptoms appear during periods of poor sleep, persistent stress, and generalized worry may reasonably discuss ashwagandha as one possible supportive measure. The expected benefit would be a gradual change in background stress or sleep quality, not guaranteed prevention of panic attacks. Confidence is lower when panic episodes are frequent, severe, unexpected, or the main problem.

The evidence is weaker for people seeking help with a diagnosed panic disorder, an acute panic episode, or anxiety associated with another untreated condition. The provided studies do not establish effectiveness in those situations. In those cases, professional assessment has a clearer role than supplement experimentation.

People interested in a wider evidence-based overview of supportive options can review Supplements for Mood & Anxiety. The key is to separate supportive strategies from treatments that have been specifically tested for the condition in question.

Practical Takeaways

• Ashwagandha has not been shown in the provided research to stop or prevent panic attacks. The available trials address chronic stress, anxiety measures, and sleep.
• Chandrasekhar et al. (2012) and Langade et al. (2019) provide randomized, placebo-controlled evidence that standardized ashwagandha root extract may improve stress- and anxiety-related outcomes in selected adults.
• The commonly reported study regimen was 300 mg of root extract twice daily, but study dosing is not a personal medical recommendation.
• Any potential benefit is likely to be gradual. The cited studies evaluated outcomes over weeks, not immediate relief during an attack.
• Choose products with transparent extract information, and do not assume evidence for one extract applies to every ashwagandha-containing formula.
• Seek clinical evaluation for new, severe, recurrent, or disabling panic symptoms, and seek urgent help for symptoms that could represent a medical emergency.

Bottom Line

Ashwagandha may support stress, anxiety, and sleep outcomes in some adults, based on the human trials reviewed here. But the evidence does not show that it treats panic disorder or works as an acute intervention for panic attacks. For recurrent panic symptoms, the most evidence-aligned approach is to use supplements cautiously, if at all, as part of—not instead of—appropriate clinical care.

References

1. Chandrasekhar K, et al. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian Journal of Psychological Medicine. 2012;34(3):255–262. [Source]
2. Langade D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety." Medicine. 2019;98(37):e17186. [Source]
3. Wankhede S, et al. "Examining the effect of Withania somnifera supplementation on muscle strength and recovery." Journal of the International Society of Sports Nutrition. 2015;12:43. [Source]
4. Choudhary D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in improving memory and cognitive functions." Journal of Dietary Supplements. 2017;14(6):599–612. [Source]
5. Pratte MA, et al. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha." Journal of Alternative and Complementary Medicine. 2014;20(12):901–908. [Source]

---

---